Clinical Trials Directory

Trials / Unknown

UnknownNCT00402519

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy After Breast Conserving Surgery for Low-risk Invasive Carcinoma and Low-risk Ductal Carcinoma in Situ (DCIS) of the Female Breast

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
1,300 (actual)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Not accepted

Summary

To assess the role of interstitial brachytherapy alone compared to whole breast irradiation in a defined low-risk group of invasive breast cancer or ductal carcinoma in situ concerning local failure (all ipsilateral local recurrences) to affirm the hypothesis that local control rates in each arm are equivalent.

Detailed description

To assess the role of interstitial brachytherapy alone compared to whole breast irradiation in a defined low-risk group of invasive breast cancer or ductal carcinoma in situ concerning local failure (all ipsilateral local recurrences) to affirm the hypothesis that local control rates in each arm are equivalent.

Conditions

Interventions

TypeNameDescription
RADIATIONAccelerated partial breast irradiationAPBI with PDR and HDR brachytherapy
RADIATIONExternal beam whole breast irradiationStandard Whole breast irradiation

Timeline

Start date
2004-11-01
Primary completion
2009-11-01
Completion
2019-11-01
First posted
2006-11-22
Last updated
2016-05-13

Locations

11 sites across 5 countries: Austria, Germany, Hungary, Poland, Spain

Source: ClinicalTrials.gov record NCT00402519. Inclusion in this directory is not an endorsement.